<--- Back to Details
First PageDocument Content
Organic chemistry / Oxybutynin / Overactive bladder / Tolterodine / Urge incontinence / Darifenacin / Solifenacin / Urinary incontinence / Anticholinergic / Medicine / Muscarinic antagonists / Chemistry
Date: 2013-07-11 15:31:30
Organic chemistry
Oxybutynin
Overactive bladder
Tolterodine
Urge incontinence
Darifenacin
Solifenacin
Urinary incontinence
Anticholinergic
Medicine
Muscarinic antagonists
Chemistry

Anticholinergics for Overactive Bladder - March 2008

Add to Reading List

Source URL: www.sasksurgery.ca

Download Document from Source Website

File Size: 61,21 KB

Share Document on Facebook

Similar Documents

OMERS / Warner Chilcott / Medicaid / Chilcott / Qui tam / False Claims Act / Risedronic acid / Darifenacin

WARNER CHILCOTT PLC PAYS $102 MILLION TO RESOLVE KICKBACK AND FALSE CLAIMS CASE The National Association of Medicaid Fraud Control Units announced on October 29, 2015, that the states and federal government joined to rea

DocID: 1oOit - View Document

Urge incontinence / Urinary incontinence / Overactive bladder / Urodynamic testing / Urinary retention / Darifenacin / Tolterodine / Oxybutynin / Urination / Medicine / Muscarinic antagonists / Incontinence

clinical Overactive bladder syndrome Management and treatment options Janine Arnold Nicholas McLeod

DocID: 124kG - View Document

Urology / Medical specialties / Surgical specialties / Urinary incontinence / Urge incontinence / Overactive bladder / Oxybutynin / Darifenacin / Stress incontinence / Medicine / Muscarinic antagonists / Incontinence

Inside Think about medicines and mobility Physical and behavioural therapies are first line

DocID: SCqS - View Document

Amines / Alcohols / Selective serotonin reuptake inhibitors / Enantiopure drugs / Darifenacin / Oxybutynin / Solifenacin / Dextromethorphan / Venlafaxine / Chemistry / Organic chemistry / Muscarinic antagonists

What’s “hot” about thermogenic agents

DocID: KPgb - View Document

Medicine / Alcohols / Amines / Overactive bladder / Incontinence / Oxybutynin / Darifenacin / Urinary incontinence / Fesoterodine / Chemistry / Muscarinic antagonists / Organic chemistry

CONTROL Trial (CL2008-13) and Safety Review - FDA perspective

DocID: C6sR - View Document